| |
| |
|
| Insider
Information: |
Manhard Kimberly |
| Relationship: |
EVP, Drug Development |
| City: |
Lafayette |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
28,330 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$97,739 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
28,330 |
|
|
| Total
Value |
$97,739 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
SVP, Regulatory & Dev ... |
2012-06-19 |
0 |
2009-05-19 |
0 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
EVP, Drug Development |
2023-04-13 |
28,330 |
2015-06-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2015-06-02 |
4 |
S |
$23.58 |
$247,590 |
D/D |
(10,500) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2017-04-24 |
4 |
AS |
$15.33 |
$330,263 |
D/D |
(21,542) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2017-04-24 |
4 |
OE |
$8.80 |
$193,643 |
D/D |
21,542 |
21,542 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-01-10 |
4 |
AS |
$20.00 |
$151,680 |
D/D |
(7,584) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-01-10 |
4 |
OE |
$13.00 |
$98,592 |
D/D |
7,584 |
7,584 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-03-19 |
4 |
AS |
$30.00 |
$540,000 |
D/D |
(18,000) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-03-19 |
4 |
OE |
$13.00 |
$234,000 |
D/D |
18,000 |
18,000 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-07-02 |
4 |
AS |
$37.51 |
$225,179 |
D/D |
(6,000) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-07-02 |
4 |
OE |
$13.00 |
$78,000 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-10-01 |
4 |
AS |
$32.07 |
$192,433 |
D/D |
(6,000) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-10-01 |
4 |
OE |
$13.00 |
$78,000 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-10-31 |
4 |
A |
$23.60 |
$11,656 |
D/D |
494 |
494 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2018-11-02 |
4 |
AS |
$30.62 |
$15,125 |
D/D |
(494) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2019-04-30 |
4 |
A |
$18.43 |
$20,437 |
D/D |
1,109 |
1,109 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• – – |
2019-05-01 |
4 |
AS |
$18.86 |
$20,918 |
D/D |
(1,109) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• • – |
2019-11-29 |
4 |
OE |
$13.00 |
$312,000 |
D/D |
24,000 |
24,000 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• • – |
2019-11-29 |
4 |
AS |
$26.00 |
$624,000 |
D/D |
(24,000) |
0 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• • – |
2020-04-30 |
4 |
A |
$12.12 |
$14,036 |
D/D |
1,158 |
1,158 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Executive VP, Drug Development |
• • – |
2020-05-01 |
4 |
AS |
$13.97 |
$16,176 |
D/D |
(1,158) |
0 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2020-12-22 |
4 |
AS |
$20.00 |
$200,000 |
D/D |
(10,000) |
0 |
0 |
% |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2020-12-22 |
4 |
OE |
$13.00 |
$130,000 |
D/D |
10,000 |
10,000 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-01-13 |
4 |
D |
$18.16 |
$7,863 |
D/D |
(433) |
817 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
1,250 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-04-13 |
4 |
D |
$16.66 |
$7,214 |
D/D |
(433) |
1,634 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
EVP, Drug Development |
• • – |
2021-04-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,250 |
2,067 |
0 |
- |
|
119 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
